Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

2.5 ML Sodium Hyaluronate 10 MG/ML Prefilled Syringe [Supartz]

Known as: 2.5 ML Supartz 10 MG/ML Prefilled Syringe, SUPARTZ FX 25 MG per 2.5 ML Prefilled Syringe, Supartz 25 MG per 2.5 ML Prefilled Syringe 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
IntroductionThis study aims to compare the properties of currently available intra-articular hyaluronate (IA-HA) products widely… Expand
  • table 1
  • table 2
Is this relevant?
2016
2016
IntroductionOsteoarthritis (OA), as one of the leading causes of disability, decreases the quality of life for those suffering… Expand
  • table 2
  • table 3
  • table 4
  • table 5
  • table 6
Is this relevant?
Review
2016
Review
2016
Although the concept of equivalence for drugs (generics) and biologics (biosimilars) has been readily adopted, the concept of… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Review
2010
Review
2010
  • M. Curran
  • Drugs & aging
  • 2010
  • Corpus ID: 22201374
Hyaluronic acid (Supartz®; molecular weight 620–1170 kDa) is a sterile, viscoelastic, non-pyogenic solution that is indicated as… Expand
Is this relevant?
Review
2010
Review
2010
IntroductionOsteoarthritis (OA) is a disease of synovial joints and is the most common cause of chronic pain… Expand
  • table 1
Is this relevant?
Review
2005
Review
2005
Objective. To evaluate the efficacy and safety of injection of high molecular weight (HMW) hyaluronan (Orthovisc®) in patients… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?